Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 631 | $399,034,323 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
27 Mar 2023 16:41 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | President and Chief Scientific | 23 Mar 2023 | Sale | 122 | 801.16 | 97,742 | I |
17 Aug 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 16 Aug 2022 | Sale | 148 | 640.91 | 94,855 | D |
08 Feb 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 07 Feb 2024 | Sale | 100 | 947.34 | 94,734 | D |
10 Nov 2022 16:00 | REGN | REGENERON PHARMACEUTICALS Inc | BROWN MICHAEL S | Director | 08 Nov 2022 | Sale | 126 | 751.23 | 94,655 | D |
29 Mar 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 28 Mar 2023 | Sale | 115 | 820.85 | 94,398 | D |
02 Nov 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 01 Nov 2022 | Sale | 119 | 761.36 | 90,602 | D |
16 Feb 2024 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 14 Feb 2024 | Sale | 95 | 945.81 | 89,852 | D |
07 Feb 2023 16:09 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 06 Feb 2023 | Sale | 113 | 784.27 | 88,623 | D |
06 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 05 Dec 2023 | Sale | 103 | 811.37 | 83,571 | D |
07 Feb 2023 16:09 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 06 Feb 2023 | Sale | 99 | 794.61 | 78,666 | D |
13 Sep 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 12 Sep 2022 | Sale | 110 | 712.44 | 78,368 | D |
16 Nov 2022 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 15 Nov 2022 | Sale | 109 | 718.6 | 78,327 | D |
07 Feb 2023 16:09 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 06 Feb 2023 | Sale | 99 | 788.62 | 78,073 | D |
17 Aug 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 16 Aug 2022 | Sale | 119 | 645.63 | 76,830 | D |
10 Nov 2022 16:00 | REGN | REGENERON PHARMACEUTICALS Inc | BROWN MICHAEL S | Director | 08 Nov 2022 | Sale | 100 | 765.19 | 76,519 | D |
10 Nov 2022 16:00 | REGN | REGENERON PHARMACEUTICALS Inc | BROWN MICHAEL S | Director | 08 Nov 2022 | Sale | 100 | 761.53 | 76,153 | D |
15 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Mar 2024 | Sale | 78 | 965.51 | 75,310 | D |
25 Nov 2022 13:07 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 23 Nov 2022 | Sale | 101 | 743.66 | 75,110 | D |
16 Nov 2022 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 15 Nov 2022 | Sale | 100 | 744.01 | 74,401 | D |
08 Nov 2022 16:00 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 07 Nov 2022 | Sale | 100 | 742.79 | 74,279 | D |
25 Nov 2022 13:07 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 23 Nov 2022 | Sale | 99 | 742.58 | 73,515 | D |
30 Dec 2022 16:10 | REGN | REGENERON PHARMACEUTICALS Inc | COLES N ANTHONY | Director | 28 Dec 2022 | Sale | 100 | 711.95 | 71,195 | D |
07 Feb 2023 16:09 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 06 Feb 2023 | Sale | 85 | 786.45 | 66,848 | D |
08 Aug 2022 16:11 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 05 Aug 2022 | Sale | 100 | 621.11 | 62,111 | D |
13 Sep 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 12 Sep 2022 | Sale | 87 | 709.93 | 61,764 | D |
07 Feb 2023 16:09 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 06 Feb 2023 | Sale | 78 | 785.88 | 61,299 | D |
02 Nov 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 01 Nov 2022 | Sale | 81 | 755.46 | 61,192 | D |
17 Aug 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 16 Aug 2022 | Sale | 94 | 643.37 | 60,477 | D |
02 Nov 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 01 Nov 2022 | Sale | 80 | 754.39 | 60,351 | D |
03 Oct 2022 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | TESSIER-LAVIGNE MARC | Director | 29 Sep 2022 | Sale | 85 | 696.13 | 59,171 | D |
16 Nov 2022 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 15 Nov 2022 | Sale | 78 | 732.4 | 57,127 | D |
13 Sep 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 12 Sep 2022 | Sale | 79 | 722.83 | 57,104 | D |
03 Oct 2022 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | TESSIER-LAVIGNE MARC | Director | 29 Sep 2022 | Sale | 80 | 699.82 | 55,986 | D |
17 Aug 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 16 Aug 2022 | Sale | 86 | 649.54 | 55,860 | D |
02 Nov 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 01 Nov 2022 | Sale | 70 | 759.39 | 53,157 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 53 | 984.02 | 52,153 | D |
13 Sep 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 12 Sep 2022 | Sale | 70 | 711.85 | 49,830 | D |
16 Nov 2022 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 15 Nov 2022 | Sale | 66 | 741.61 | 48,946 | D |
17 Aug 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 16 Aug 2022 | Sale | 76 | 639.85 | 48,629 | D |
06 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 05 Dec 2023 | Sale | 58 | 814.06 | 47,215 | D |
16 Nov 2022 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 15 Nov 2022 | Sale | 64 | 734.59 | 47,014 | D |
07 Feb 2023 16:09 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 06 Feb 2023 | Sale | 59 | 795.41 | 46,929 | D |
07 Feb 2023 16:09 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 06 Feb 2023 | Sale | 58 | 787.47 | 45,673 | D |
15 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Mar 2024 | Sale | 47 | 961.74 | 45,202 | D |
16 Nov 2022 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 15 Nov 2022 | Sale | 57 | 723.19 | 41,222 | D |
29 Mar 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 27 Mar 2023 | Sale | 50 | 820.46 | 41,023 | D |
07 Feb 2023 16:09 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 06 Feb 2023 | Sale | 51 | 783.05 | 39,936 | D |
29 Mar 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 27 Mar 2023 | Sale | 48 | 821.39 | 39,427 | D |
25 Aug 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 24 Aug 2023 | Sale | 46 | 840.74 | 38,674 | D |
07 Feb 2023 16:09 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 06 Feb 2023 | Sale | 49 | 789.05 | 38,663 | D |
27 Mar 2023 16:41 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | President and Chief Scientific | 23 Mar 2023 | Sale | 47 | 805.55 | 37,861 | I |
08 Nov 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 07 Nov 2023 | Sale | 39 | 828.54 | 32,313 | D |
29 Mar 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 27 Mar 2023 | Sale | 39 | 819.47 | 31,959 | D |
02 Nov 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 01 Nov 2022 | Sale | 42 | 758.2 | 31,844 | D |
02 Nov 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 01 Nov 2022 | Sale | 40 | 753.23 | 30,129 | D |
05 Apr 2023 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Apr 2023 | Sale | 32 | 819.48 | 26,223 | D |
04 Jan 2024 16:08 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 02 Jan 2024 | Sale | 29 | 900.59 | 26,117 | D |
29 Mar 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 28 Mar 2023 | Sale | 31 | 826.36 | 25,617 | D |
03 May 2023 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 May 2023 | Sale | 30 | 803.58 | 24,107 | D |
02 Jun 2023 16:14 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Jun 2023 | Sale | 31 | 736.4 | 22,828 | D |
07 Feb 2023 16:09 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 06 Feb 2023 | Sale | 28 | 797.43 | 22,328 | D |
05 Apr 2023 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Apr 2023 | Sale | 27 | 818.47 | 22,099 | D |
04 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Dec 2023 | Sale | 27 | 811.48 | 21,910 | D |
06 Jul 2023 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Jul 2023 | Sale | 29 | 716.74 | 20,785 | D |
03 Nov 2022 16:03 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Nov 2022 | Sale | 26 | 756.31 | 19,664 | D |
02 Dec 2022 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Dec 2022 | Sale | 26 | 755.47 | 19,642 | D |
03 Apr 2024 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Apr 2024 | Sale | 20 | 963.6 | 19,272 | D |
05 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Mar 2024 | Sale | 19 | 984.45 | 18,705 | D |
03 Feb 2023 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Feb 2023 | Sale | 24 | 756.77 | 18,162 | D |
08 Feb 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 07 Feb 2024 | Sale | 19 | 953 | 18,107 | D |
05 Oct 2022 16:10 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Oct 2022 | Sale | 24 | 733.64 | 17,607 | D |
15 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Mar 2024 | Sale | 17 | 966.3 | 16,427 | D |
03 Aug 2023 16:25 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Aug 2023 | Sale | 22 | 735.55 | 16,182 | D |
06 Jul 2023 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Jul 2023 | Sale | 22 | 717.57 | 15,787 | D |
16 Nov 2022 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 15 Nov 2022 | Sale | 21 | 742.25 | 15,587 | D |
03 Apr 2024 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Apr 2024 | Sale | 16 | 964.45 | 15,431 | D |
16 Nov 2022 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 15 Nov 2022 | Sale | 21 | 733.42 | 15,402 | D |
15 Nov 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Nov 2023 | Sale | 19 | 805 | 15,295 | D |
15 Nov 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Nov 2023 | Sale | 19 | 804.89 | 15,293 | D |
03 May 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 May 2024 | Sale | 17 | 898.51 | 15,275 | D |
02 Dec 2022 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Dec 2022 | Sale | 20 | 756.35 | 15,127 | D |
08 Nov 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 07 Nov 2023 | Sale | 18 | 829.43 | 14,930 | D |
08 Nov 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 07 Nov 2023 | Sale | 18 | 825.53 | 14,860 | D |
29 Mar 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 27 Mar 2023 | Sale | 18 | 822.57 | 14,806 | D |
05 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Mar 2024 | Sale | 15 | 981.64 | 14,725 | D |
02 Nov 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 01 Nov 2022 | Sale | 19 | 763.1 | 14,499 | D |
03 Apr 2024 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Apr 2024 | Sale | 15 | 960.53 | 14,408 | D |
07 Feb 2023 16:09 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 06 Feb 2023 | Sale | 18 | 796.43 | 14,336 | D |
03 Oct 2022 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | TESSIER-LAVIGNE MARC | Director | 29 Sep 2022 | Sale | 20 | 704.83 | 14,097 | D |
05 Oct 2022 16:10 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Oct 2022 | Sale | 19 | 728.23 | 13,836 | D |
03 May 2023 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 May 2023 | Sale | 17 | 807.5 | 13,728 | D |
03 Nov 2022 16:03 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Nov 2022 | Sale | 18 | 755.5 | 13,599 | D |
03 Feb 2023 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Feb 2023 | Sale | 18 | 753.54 | 13,564 | D |
03 Apr 2024 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Apr 2024 | Sale | 14 | 961.59 | 13,462 | D |
03 Aug 2023 16:25 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Aug 2023 | Sale | 18 | 734.56 | 13,222 | D |
05 Oct 2022 16:10 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Oct 2022 | Sale | 18 | 727.52 | 13,095 | D |
03 Mar 2023 16:03 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Mar 2023 | Sale | 17 | 764.49 | 12,996 | D |
02 Nov 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 01 Nov 2022 | Sale | 17 | 762.92 | 12,970 | D |
03 Feb 2023 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Feb 2023 | Sale | 17 | 755.5 | 12,844 | D |
03 May 2023 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 May 2023 | Sale | 16 | 802.67 | 12,843 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)